SAVIMS

SAVIMS logo white
Menu

COVID-19

COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine effectiveness, Vaccines, Viral illnesses

Reduced Reinfection Risk with Vaccination in Previously Infected Individuals

| | COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine effectiveness, Vaccines, Viral illnesses

Reference: Cavanaugh, A. M., Spicer, K. B., Thoroughman, D., Glick, C., & Winter, K. (2021). Reduced risk of reinfection with SARS-CoV-2 after COVID-19 vaccination – Kentucky, May–June 2021. Morbidity and Mortality Weekly Report, 70(32), 1081-1083. https://www.cdc.gov/mmwr/volumes/70/wr/pdfs/mm7032e1-H.pdf Summary: A study conducted in Kentucky investigated the impact of COVID-19 vaccination on reinfection rates among individuals previously infected […]

COVID-19, Ethics, Other scientific evidence, Reference Library, Resource Type, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

Rising Hospitalisations Among Vaccinated Individuals in Israel

| | COVID-19, Ethics, Other scientific evidence, Reference Library, Resource Type, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: Johnson, L. D. (2021, August 11). 95% of severe patients in Israeli hospitals are vaccinated, warns doctor. Natural News. https://www.naturalnews.com/2021-08-11-95-severe-patients-israeli-hospitals-are-vaccinated.html Summary: Dr. Kobi Haviv reports a troubling trend in Israel, where 95% of severe COVID-19 patients in hospitals are vaccinated. Despite over 78% vaccination coverage, Israel has experienced a rise in serious cases. The

COVID-19, Reference Library, SAVIMS Documents, SAVIMS Publications, Vaccines

Covid-19 pandemic health and economic crises: Open letter to President Ramaphosa

| | COVID-19, Reference Library, SAVIMS Documents, SAVIMS Publications, Vaccines

Summary In an open letter to President Ramaphosa, the authors express grave concerns about the handling of the COVID-19 pandemic in South Africa, criticising the reliance on official narratives from global health organisations and mainstream media, and highlighting the adverse effects of these policies on public health and the economy. They argue that current mRNA

COVID-19, Covid-19 vaccines, Epidemiological surveillance, Other scientific evidence, Resource Type, Statistical evidence, Vaccine effectiveness, Vaccines, Viral illnesses

Shedding of Infectious SARS-CoV-2 Despite Vaccination

| | COVID-19, Covid-19 vaccines, Epidemiological surveillance, Other scientific evidence, Resource Type, Statistical evidence, Vaccine effectiveness, Vaccines, Viral illnesses

Reference: Riemersma, K. K., Haddock, L. A. III, Wilson, N. A., Minor, N., Eickhoff, J., Grogan, B. E., Kita-Yarbro, A., Halfmann, P. J., Segaloff, H. E., Kocharian, A., Florek, K. R., Westergaard, R., Bateman, A., Jeppson, G. E., Kawaoka, Y., O’Connor, D. H., Friedrich, T. C., & Grande, K. M. (2022). Shedding of infectious SARS-CoV-2

COVID-19, Ivermectin, Other scientific evidence, Resource Type, Treatment, Viral illnesses

Ivermectin for COVID-19: Evidence Review

| | COVID-19, Ivermectin, Other scientific evidence, Resource Type, Treatment, Viral illnesses

Reference: South African National Department of Health. (2021). Rapid review of Ivermectin for COVID-19: Evidence review of clinical benefits and harms (Update: 30 July 2021). Summary: The South African National Department of Health conducted a rapid review to assess the efficacy of ivermectin in treating COVID-19. The review, which synthesised findings from multiple randomised controlled

COVID-19, Covid-19 vaccines, Epidemiological surveillance, Peer-reviewed evidence, Resource Type, Statistical evidence, Vaccine effectiveness, Vaccines, Viral illnesses

Impact of the SARS-CoV-2 Delta Variant and Vaccine Efficacy

| | COVID-19, Covid-19 vaccines, Epidemiological surveillance, Peer-reviewed evidence, Resource Type, Statistical evidence, Vaccine effectiveness, Vaccines, Viral illnesses

Reference: Tareq, A. M., Bin Emran, T., Dhama, K., Dhawan, M., & Tallei, T. E. (2021). Impact of SARS-CoV-2 delta variant (B.1.617.2) in surging second wave of COVID-19 and efficacy of vaccines in tackling the ongoing pandemic. Human Vaccines & Immunotherapeutics, 17(11), 4126–4127. https://doi.org/10.1080/21645515.2021.1963601 Summary: The article examines the impact of the SARS-CoV-2 delta variant

COVID-19, Reference Library, SAVIMS Documents, SAVIMS Publications

COVID-19: Good News (July 2021)

| | COVID-19, Reference Library, SAVIMS Documents, SAVIMS Publications

Summary The document, authored by Dr. Herman J. Edeling, outlines positive developments in COVID-19 prevention and treatment as of July 2021. It emphasises the availability of effective, safe, and affordable preventive measures such as nutraceuticals (Vitamin D3, Zinc, Vitamin C, Quercetin, Melatonin) and the anti-infective agent Ivermectin. For symptomatic individuals, early home-based treatments including increased

COVID-19, Ivermectin, Other scientific evidence, Resource Type, Treatment, Viral illnesses

A database of all Ivermectin studies for treatment of COVID-19

| | COVID-19, Ivermectin, Other scientific evidence, Resource Type, Treatment, Viral illnesses

Reference: Search results obtained to compile a database of all the studies done on Ivermecting as therapeutic drug for COVID-19. 2021-07-18. Summary: Database of all Ivermectin COVID-19 studies. 101 studies, 66 peer reviewed, 60 with results comparing treatment and control groups. DOWNLOAD

COVID-19, Other scientific evidence, Resource Type, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

Breakthrough Infections Post-Pfizer Vaccination: Insights from an Israeli Study

| | COVID-19, Other scientific evidence, Resource Type, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: Brosh-Nissimov, T. et al. (2021). BNT162b2 vaccine breakthrough: clinical characteristics of 152 fully-vaccinated hospitalized COVID-19 patients in Israel. Clinical Microbiology and Infection. https://doi.org/10.1016/j.cmi.2021.06.036 Summary: A study conducted in Israel examined breakthrough infections in fully-vaccinated patients who were hospitalised with COVID-19. Out of 152 patients, 40% were immunocompromised, and the study revealed that despite the

COVID-19, Ivermectin, Nutritional supplements, Other repurposed substances, Other scientific evidence, Resource Type, Treatment, Viral illnesses

Community Health Initiative Against Covid-19

| | COVID-19, Ivermectin, Nutritional supplements, Other repurposed substances, Other scientific evidence, Resource Type, Treatment, Viral illnesses

Reference: Okahandja Community Forum. (2021, July 9). An Okahandja community project: What you can do at home. Summary: The Okahandja community project, initiated on 9 July 2021, provides guidance for individuals on how to manage health concerns related to Covid-19. Emphasising the importance of prevention and patient support, the document outlines necessary hygiene measures, such

Scroll to Top